These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7696609)
1. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia. Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609 [TBL] [Abstract][Full Text] [Related]
2. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome. Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224 [TBL] [Abstract][Full Text] [Related]
3. A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome. Tyrrell J; Cosgrave M; Hawi Z; McPherson J; O'Brien C; McCalvert J; McLaughlin M; Lawlor B; Gill M Biol Psychiatry; 1998 Mar; 43(6):397-400. PubMed ID: 9532343 [TBL] [Abstract][Full Text] [Related]
4. ApoE2 allele, Down's syndrome, and dementia. Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Ragbavan R; Khin-Nu C; Tyner S; Day K; Crook R; Hardy J; Roberts GW Ann N Y Acad Sci; 1996 Jan; 777():255-9. PubMed ID: 8624094 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the APOE alleles impact in Down's syndrome. Lambert JC; Pérez-Tur J; Dupire MJ; Delacourte A; Frigard B; Chartier-Harlin MC Neurosci Lett; 1996 Dec; 220(1):57-60. PubMed ID: 8977148 [TBL] [Abstract][Full Text] [Related]
6. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing. van Gool WA; Evenhuis HM; van Duijn CM Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070 [TBL] [Abstract][Full Text] [Related]
7. Onset of dementia is associated with age at menopause in women with Down's syndrome. Schupf N; Pang D; Patel BN; Silverman W; Schubert R; Lai F; Kline JK; Stern Y; Ferin M; Tycko B; Mayeux R Ann Neurol; 2003 Oct; 54(4):433-8. PubMed ID: 14520653 [TBL] [Abstract][Full Text] [Related]
8. [The apolipoprotein E genotype and Down's syndrome]. Rascón Trincado MV; González Sarmiento R; Salazar A-Villalobos V Rev Clin Esp; 1997 Oct; 197(10):680-3. PubMed ID: 9424665 [TBL] [Abstract][Full Text] [Related]
9. Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome. Schupf N; Kapell D; Lee JH; Zigman W; Canto B; Tycko B; Mayeux R Ann Neurol; 1996 Nov; 40(5):799-801. PubMed ID: 8957023 [TBL] [Abstract][Full Text] [Related]
10. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Hyman BT; West HL; Rebeck GW; Lai F; Mann DM Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373 [TBL] [Abstract][Full Text] [Related]
11. ApoE genotype and Alzheimer's disease in adults with Down syndrome: meta-analysis. Prasher VP; Chowdhury TA; Rowe BR; Bain SC Am J Ment Retard; 1997 Sep; 102(2):103-10. PubMed ID: 9327086 [TBL] [Abstract][Full Text] [Related]
12. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Martins RN; Clarnette R; Fisher C; Broe GA; Brooks WS; Montgomery P; Gandy SE Neuroreport; 1995 Jul; 6(11):1513-6. PubMed ID: 7579137 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Saunders AM; Schmader K; Breitner JC; Benson MD; Brown WT; Goldfarb L; Goldgaber D; Manwaring MG; Szymanski MH; McCown N Lancet; 1993 Sep; 342(8873):710-1. PubMed ID: 8103823 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome. Sekijima Y; Ikeda S; Tokuda T; Satoh S; Hidaka H; Hidaka E; Ishikawa M; Yanagisawa N Eur Neurol; 1998; 39(4):234-7. PubMed ID: 9635475 [TBL] [Abstract][Full Text] [Related]
15. Genetic and host factors for dementia in Down's syndrome. Schupf N; Sergievsky GH Br J Psychiatry; 2002 May; 180():405-10. PubMed ID: 11983636 [TBL] [Abstract][Full Text] [Related]
17. The impact of apolipoprotein E on dementia in persons with Down's syndrome. Coppus AM; Evenhuis HM; Verberne GJ; Visser FE; Arias-Vasquez A; Sayed-Tabatabaei FA; Vergeer-Drop J; Eikelenboom P; van Gool WA; van Duijn CM Neurobiol Aging; 2008 Jun; 29(6):828-35. PubMed ID: 17250929 [TBL] [Abstract][Full Text] [Related]
18. Reduced survival of apolipoprotein E4 homozygotes in Down's syndrome? Holder JL; Habbak RA; Pearlson GD; Aylward EA; Pulsifer M; Warren AC Neuroreport; 1996 Nov; 7(15-17):2455-6. PubMed ID: 8981402 [TBL] [Abstract][Full Text] [Related]
19. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome. Wisniewski T; Morelli L; Wegiel J; Levy E; Wisniewski HM; Frangione B Ann Neurol; 1995 Jan; 37(1):136-8. PubMed ID: 7818249 [No Abstract] [Full Text] [Related]
20. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Hanney M; Prasher V; Williams N; Jones EL; Aarsland D; Corbett A; Lawrence D; Yu LM; Tyrer S; Francis PT; Johnson T; Bullock R; Ballard C; Lancet; 2012 Feb; 379(9815):528-36. PubMed ID: 22236802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]